VC Fund Investments
Pharma-focused B2B SaaS startup Leucine raises $7-M
Leucine, a Bengaluru- and New York, NY (USA)-based B2B software-as-a-service startup, has attracted USD 7 million Series A round led by US-based strategic investor Ecolab Inc with participation from VC investors Pravega Ventures and Axilor Ventures, apart from Techstars and angel investors. Leucine's Compliance Cloud platform functions as a “digital twin†of pharmaceutical manufacturing floors, offering real-time performance monitoring, compliance management, and actionable insights. The investment is expected to fast-track its development as well as the firm's artificial intelligence (AI)-driven tools tailored for the pharmaceutical manufacturing sector. The firm has announced the beta launch of Leucine10x, an AI framework intended to assist in pharmaceutical manufacturing processes.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
